Clinical trials sponsored by Sunnybrook Health Sciences Centre

Phase breakdown

Conditions studied

Recruiting trials led by Sunnybrook Health Sciences Centre

• 2 Ablative RadioTherapy Treatments for Prostate Cancer
  NCT04654338 · Phase: Phase 2, Phase 3 · Ages: No age limits stated · Sex: Male · 1 location
• Cannabidiol Medication Intervention Trial
  NCT06014424 · Phase: Phase 2 · Ages: 55 Years and older · Sex: All (male and female) · 5 locations
• Combined Brain Stimulation and Methylphenidate Treatment for Apathy in Dementia
  NCT07279740 · Phase: Phase 2 · Ages: No age limits stated · Sex: All (male and female) · 1 location
• ENhancing Outcomes in Cognitive Impairment Through Use of Home Sleep ApNea Testing
  NCT04335994 · Phase: Not applicable (e.g. observational or device study) · Ages: No age limits stated · Sex: All (male and female) · 1 location
• Effect of peRiopErative duLoxetIne Administration on Opioid Consumption Following Total kneE Arthroplasty (RELIFE)
  NCT06423716 · Phase: Phase 4 · Ages: 50 Years and older · Sex: All (male and female) · 2 locations
• Evaluating the Impact of Virtual Reality on Mood in Patients Undergoing Magnetic Resonance-Guided Focused Ultrasound for Medication-Refractory Essential Tremor
  NCT07287605 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Focused Ultrasound Neuromodulation in Patients With Treatment-Resistant Depression
  NCT07094789 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• Hepatic Arterial Infusion Chemotherapy in Patients With Inoperable Colorectal Cancer Liver Metastasis
  NCT07764497 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• I-CARE: A Pilot Study of Cognitive Behavioural Therapy(CBT) for Mood and Anxiety Disorders
  NCT06532500 · Phase: Not applicable (e.g. observational or device study) · Ages: 14 Years to 19 Years · Sex: All (male and female) · 1 location
• Improving Sexual Quality of Life - Randomized Trial of Two vs Five MRI Guided SABR Treatments for Prostate Cancer
  NCT05600400 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Male · 1 location
• InTRavenous kEtAmine and immerSive virtUal Reality to Treat dEpression
  NCT06781697 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Interleaved TMS-fMRI in Ultra-treatment Resistant Depression
  NCT05813093 · Phase: Not applicable (e.g. observational or device study) · Ages: 20 Years to 65 Years · Sex: All (male and female) · 1 location
• Levetiracetam for Persons at Risk for Alzheimer's Disease
  NCT07477431 · Phase: Phase 2 · Ages: 55 Years to 85 Years · Sex: All (male and female) · 2 locations
• MRI Screening for Brain Metastases Among Patients With Triple Negative or HER2+ Stage II or III Breast Cancer
  NCT06247449 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• MRI-Guided Focused Ultrasound Radiosensitization for Patients With Malignant Melanoma and Non Melanoma Skin Cancer
  NCT05620290 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• MRI-Guided Ultrasound Stimulated Microbubbles Radiation Treatment for Patients with Chest-Wall and Locally Advanced Breast Cancer
  NCT06633601 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Magnetic Resonance-Guided Focused Ultrasound Bilateral Capsulotomy for Refractory Anorexia Nervosa With Comorbid Obsessive Compulsive Disorder or Major Depressive Disorder
  NCT07113665 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 2 locations
• Magnetic Resonance-Guided Focused Ultrasound Bilateral Capsulotomy for the Treatment of Refractory Bipolar Depression
  NCT07108257 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• Metabolic Imaging of the Heart Using Hyperpolarized (13C) Pyruvate Injection
  NCT02648009 · Phase: Phase 1 · Ages: 19 Years to 75 Years · Sex: All (male and female) · 2 locations
• Nabilone for Agitation Blinded Intervention Trial
  NCT04516057 · Phase: Phase 3 · Ages: 55 Years and older · Sex: All (male and female) · 6 locations
• Oral Versus Intramuscular Steroid Use to Control Rheumatoid Arthritis Flares
  NCT07245732 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 5 locations
• Photoacoustic Imaging for Characterizing Breast Masses and Breast Tumor Response to Neoadjuvant Chemotherapy
  NCT04428528 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · 1 location
• Pilot Study of Dose Escalation in Prostate Radiotherapy Using the MR-Linac (DESTINATION-MRL)
  NCT06177093 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Male · 1 location
• Prospective Assessment of Acute Skin Toxicities in Breast Cancer Patients Undergoing Retreatment with 40 Gy in 15 Fractions Radiation Therapy
  NCT06729814 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Safety and Feasibility of FUS Next Generation Dome Helmet (NGDH) to Perform Neuromodulation in Patients With Treatment Refractory Obsessive Compulsive Disorder (OCD)
  NCT07704632 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 85 Years · Sex: All (male and female) · 1 location
• Stereotactic Ablative Radiation Therapy for Abiraterone-Resistant, Oligoprogressive Metastatic Prostate Cancer
  NCT04838899 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Male · 1 location
• The Canadian CABG or PCI in Patients With Ischemic Cardiomyopathy Trial (STICH3C)
  NCT05427370 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 43 locations
• The HEROES Trial: Hyperbaric Oxygen Therapy for Endometriosis-Related Pain
  NCT06579040 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• The Sunnybrook Type 2 Diabetes Study
  NCT04455867 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Ultrasound Imaging and Spectroscopy as Early Indicators of Locally-Advanced Breast Cancer Response
  NCT04134780 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 3 locations
• Ultrasound Imaging, Spectroscopy and Ultrasound Imaging of Vascular Blood Flow as Early Indicators of Breast Cancer Response to Neoadjuvant Treatment.
  NCT00437879 · Phase: Not specified · Ages: No age limits stated · Sex: Female · 1 location
• Ultrasound Spectroscopy as Early Indicators of Radiation Treatment Response in Prostate, Rectum and Head & Neck Cancers
  NCT03908684 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · 1 location
• Use of Quantitative Ultrasound to Guide Adaptive Chemotherapy Among Women With Breast Cancer
  NCT04050228 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female · 1 location
• Using Rectal Hydrogel Spacer for Salvage SABR in Prostate Cancer
  NCT05597852 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Male · 1 location
• rTMS for Apathy Clinical Trial
  NCT05561205 · Phase: Not applicable (e.g. observational or device study) · Ages: No age limits stated · Sex: All (male and female) · 1 location
• rTMS for Youth Inpatients With Depression
  NCT07140575 · Phase: Not applicable (e.g. observational or device study) · Ages: 14 Years to 19 Years · Sex: All (male and female) · 1 location

Common questions

How many trials is Sunnybrook Health Sciences Centre recruiting for?

Sunnybrook Health Sciences Centre is the lead sponsor of 36 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.